GetPortalImpactFactorByIdResp(projectId=1, id=843216244, cover=https://img.medsci.cn/2020617/1592352185722_4754896.gif, fullname=JACC: CardioOncology, abbr=JACC-CARDIOONCOL, pyear=2019, frequence=季刊, articleNumbers=121, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2月, reviewFee=1000.0, pageFee=500.0, publishedRatio=, issn=2666-0873, greenSci=https://www.greensci.net/search?kw=2666-0873, scijournal=https://www.scijournal.org/impact-factor-of-JACC-CARDIOONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.982, medsciHotlight=1.973, medsciHotlight5year=0.747, citescore=2.1, hIndex=0, impactFactor=11.1, orgnization=Elsevier, orgnizationUrl=https://www.onlinejacc.org/, country=USA, countryCn=美国, isOa=1, isOaString=是, sciScie=null, bigclassCas=null, smallclassCas=医学 2 区, website=https://cardiooncology.onlinejacc.org/, websiteHits=702, guideForAuthor=https://www.jaccsubmit-cardiooncology.org/cgi-bin/main.plex?form_type=display_auth_instructions, guideForAuthorHits=370, submitWebsite=https://www.jaccsubmit-cardiooncology.org/cgi-bin/main.plex, submitWebsiteHits=485, content=<p><em style="color: #505050;">JACC: CardioOncology</em><span style="color: #505050;"> is one of a family of specialist journals launched by the renowned </span><a style="color: #007398;" href="https://www.journals.elsevier.com/journal-of-the-american-college-of-cardiology" rel=""><em>Journal of the American College of Cardiology (JACC)</em></a><span style="color: #505050;">. It serves to advance the cardiovascular care of cancer patients through the publication of rigorously executed, innovative science and dissemination of evidence-based knowledge. The journal seeks to transform the field of cardio-oncology and actively engage and educate the cardiovascular and oncology communities in pre-clinical, translational, and clinical research, as well as in best practices in cardio-oncology. Broad areas of interest include original research studies in disease mechanisms, in vitro and in vivo model systems, novel and conventional therapeutics (Phase I-IV), epidemiology, precision medicine, and primary and secondary prevention. Disease states of interest include, but are not limited to amyloidosis, cardiovascular risk factors, heart failure, and vascular disease.</span></p>, totalCites=1345, brief=JACC-CARDIOONCOL杂志暂不明确行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=JACC-CARDIOONCOL在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=843216244'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=110297, tagName=肿瘤心脏学, createdHits=2), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1), ImpactFactorTagDto(id=1246, tagName=免疫治疗, createdHits=1), ImpactFactorTagDto(id=9129, tagName=心脏损伤, createdHits=1), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1), ImpactFactorTagDto(id=87554, tagName=心脏肿瘤学, createdHits=1)], citeScoreList=null, medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.241), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.861), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.855), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.982)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2666-0873[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=JACC: CardioOncology[ta], article_number=84, article_number_cn=null, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)